C=Cc1ccc(Cn2c(=O)n(-c3ccccc3C)c(=O)c3c4c(sc32)CN(C(C)=O)CC4)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?